Skip to main content
Fig. 4 | Breast Cancer Research

Fig. 4

From: miR-105/93-3p promotes chemoresistance and circulating miR-105/93-3p acts as a diagnostic biomarker for triple negative breast cancer

Fig. 4

miR-93-3p/105 act as a predictive biomarker for TNBC. a miR-93-3p and miR-105 levels were determined in 13 TNBC and 12 non-TNBC N-T pairs by qPCR. b Overall survival of 114 triple negative breast cancer patients was analyzed by Kaplan-Meier analysis after stratification by miR-93-3p/miR-105 expression. c SFRP1 levels were determined in 13 TNBC N-T paired tissues by immunoblotting. d Overall survival of 93 triple negative breast cancer patients that had previously received chemotherapy was obtained from the Kaplan-Meier plotter website. Using the median level as a cutoff, samples were stratified by SFRP1 levels to test the correlation with overall survival. TNBC triple negative breast cancer

Back to article page

Breast Cancer Research

ISSN: 1465-542X

Contact us